ORMP
Oramed Pharmaceuticals Inc.Company with tickers: ORMP
CIK
1176309
CUSIP
68403P203
Shares Outstanding
40,926,081
Website
https://www.oramed.com
Investor Relations
https://oramed.com/investor-relations/
13F Activity (30d)
21 filings
19 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$469,000
as of 2026-03-31
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $4,741,000 | 10-K, filed 2026-03-26 |
| 2024-12-31 | $2,484,000 | 10-K, filed 2026-03-26 |
Recent quarters
| Quarter Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $4,009,000 Δ | 10-K, filed 2026-03-26 |
| 2025-09-30 | $361,000 Δ | 10-Q, filed 2025-11-13 |
| 2024-12-31 | $1,193,000 Δ | 10-K, filed 2026-03-26 |